Myelodysplastic syndrome

Myelodysplastic syndrome overview

You are at the center of everything we do at Seattle Cancer Care Alliance (SCCA). Here, we surround you with a team of specialists who work together closely to provide expertly targeted, complete care and compassionate support throughout your treatment and beyond.

We guide you every step of the way, combining our deep clinical expertise in myelodysplastic syndrome (MDS) with a commitment to meet your unique needs.

Why choose SCCA for MDS treatment?

  • Expert MDS diagnosis and care
    SCCA is recognized as a Center of Excellence by the Myelodysplastic Syndromes Foundation. Our patients receive state-of-the-art evaluation, using new tools to pinpoint your diagnosis and determine where you are in the spectrum of MDS. We’re a world leader in research to better understand and more effectively treat this group of diseases.
  • Clear information about your options
    Research shows that many people with MDS are not made aware of their prognosis and are not properly informed about the effectiveness of different treatment approaches if they receive care at a center that doesn't specialize in MDS, like SCCA does. We strive to make sure you understand your condition and what to expect.
  • Bone marrow transplant for MDS
    The Fred Hutch Bone Marrow Transplant Program at SCCA consistently achieves higher-than-expected transplant survival rates. We have performed more bone marrow and stem cell transplants than any other institution in the world and are investigating novel transplant approaches to improve overall survival for people with MDS.
  • NCI comprehensive cancer center
    We are a comprehensive cancer center, a designation from the National Cancer Institute that reflects our scientific leadership and the depth and breadth of our research to prevent, diagnose and treat cancer. Our doctors and scientists bring the same commitment to MDS and other blood-related diseases.

Treatment

Our doctors provide the full spectrum of MDS therapies, such as the growth factor erythropoietin, the medicines azacitidine (Vidaza) and decitabine (Dacogen), and chemotherapy for advanced disease. In addition, we offer promising new agents and bone marrow transplantation, the only treatment with the potential to cure MDS.

Providers

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.

Clinical trials

To give you access to the most innovative therapies, SCCA unites the leading researchers and cancer specialists of Fred Hutch and UW Medicine so you can take part in MDS clinical studies not available everywhere.